MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 58 filers reported holding MILLENDO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $38,000 | -49.3% | 31,690 | -9.9% | 0.00% | – |
Q4 2020 | $75,000 | +11.9% | 35,165 | -14.6% | 0.00% | – |
Q3 2020 | $67,000 | +8.1% | 41,155 | +17.0% | 0.00% | – |
Q2 2020 | $62,000 | -92.4% | 35,173 | -77.3% | 0.00% | – |
Q1 2020 | $817,000 | +3.9% | 154,731 | +32.7% | 0.00% | – |
Q4 2019 | $786,000 | -1.4% | 116,614 | +4.0% | 0.00% | – |
Q3 2019 | $797,000 | +67.1% | 112,120 | +171.5% | 0.00% | – |
Q2 2019 | $477,000 | – | 41,289 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,396,615 | $9,930,000 | 3.10% |
NEA Management Company, LLC | 1,766,779 | $12,562,000 | 1.04% |
Samsara BioCapital, LLC | 186,540 | $1,326,000 | 0.90% |
GREAT POINT PARTNERS LLC | 1,288,093 | $9,158,000 | 0.84% |
Bpifrance SA | 1,078,670 | $7,669,000 | 0.83% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $1,264,000 | 0.58% |
ADAMS STREET PARTNERS LLC | 367,935 | $2,616,000 | 0.52% |
Prosight Management, LP | 52,051 | $370,000 | 0.20% |
GMT CAPITAL CORP | 53,419 | $380,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 38,881 | $276,000 | 0.00% |